Pathobiology of myomatosis uteri: the underlying knowledge to support our clinical practice

[1]  Qiwei Yang,et al.  Endocrine-disrupting chemicals and uterine fibroids. , 2016, Fertility and sterility.

[2]  G. Ricci,et al.  A Proteomic Approach for the Identification of Up-Regulated Proteins Involved in the Metabolic Process of the Leiomyoma , 2016, International journal of molecular sciences.

[3]  Haibo Wang,et al.  The indication and curative effect of hysteroscopic and laparoscopic myomectomy for type II submucous myomas , 2016, BMC Surgery.

[4]  L. Aaltonen,et al.  Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers , 2016, Proceedings of the National Academy of Sciences.

[5]  A C Gore,et al.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. , 2015, Endocrine reviews.

[6]  J. Teixeira,et al.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. , 2015, Human reproduction update.

[7]  K. Burdon.  Role of direct‐to‐consumer genetic testing for complex disease in diagnostics and research , 2015, Clinical & experimental ophthalmology.

[8]  A. Al-Hendy,et al.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy , 2015, Molecular medicine.

[9]  S. Bulun,et al.  Tissue-Specific Stem Cells in the Myometrium and Tumor-Initiating Cells in Leiomyoma1 , 2014, Biology of reproduction.

[10]  L. Aaltonen,et al.  Genomics of uterine leiomyomas: insights from high-throughput sequencing. , 2014, Fertility and sterility.

[11]  C. Simón.  Introduction: Are we advancing in our scientific understanding and therapeutic improvement of uterine fibroids… or not? , 2014, Fertility and sterility.

[12]  J. Segars,et al.  The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. , 2014, Human reproduction update.

[13]  Md Soriful Islam,et al.  Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction , 2013, Obstetrics and gynecology international.

[14]  A. Al-Hendy,et al.  Racial and Ethnic Differences in the Pathogenesis and Clinical Manifestations of Uterine Leiomyoma , 2013, Seminars in Reproductive Medicine.

[15]  L. Aaltonen,et al.  Characterization of uterine leiomyomas by whole-genome sequencing. , 2013, The New England journal of medicine.

[16]  F. Petraglia,et al.  Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. , 2013, Fertility and sterility.

[17]  A. Al-Hendy,et al.  Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study , 2013, International journal of women's health.

[18]  Xiao Chen,et al.  Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. , 2012, The Cochrane database of systematic reviews.

[19]  J. Segars,et al.  Integrin β1 regulates leiomyoma cytoskeletal integrity and growth. , 2012, Matrix biology : journal of the International Society for Matrix Biology.

[20]  Elizabeth C. Sefton,et al.  The role of progesterone signaling in the pathogenesis of uterine leiomyoma , 2012, Molecular and Cellular Endocrinology.

[21]  I. Osterloh,et al.  Ulipristal acetate versus placebo for fibroid treatment before surgery. , 2012, The New England journal of medicine.

[22]  C. Walker.  Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthood. , 2011, Birth defects research. Part A, Clinical and molecular teratology.

[23]  Md Soriful Islam,et al.  Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. , 2011, Human reproduction update.

[24]  R. De Dominici,et al.  Uterine myomas during pregnancy: a longitudinal sonographic study , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[25]  Md Soriful Islam,et al.  Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid. , 2011, The Journal of clinical endocrinology and metabolism.

[26]  A. Olshan,et al.  Pregnancy-related fibroid reduction. , 2010, Fertility and sterility.

[27]  T. Amer,et al.  Uterine Artery Occlusion for Treatment of Symptomatic Uterine Myomas , 2010, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

[28]  J. Spies,et al.  Uterine Artery Embolization for Fibroids: A Review of Current Outcomes , 2010, Seminars in reproductive medicine.

[29]  N. Chegini,et al.  Proinflammatory and Profibrotic Mediators: Principal Effectors of Leiomyoma Development as a Fibrotic Disorder , 2010, Seminars in reproductive medicine.

[30]  Hanlee P. Ji,et al.  Next-generation DNA sequencing , 2008, Nature Biotechnology.

[31]  H. Masuzaki,et al.  Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas. , 2006, Human reproduction.

[32]  S. Rogatto,et al.  Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis. , 2005, American journal of obstetrics and gynecology.

[33]  J. Copland,et al.  Uterine Leiomyomas Express Myometrial Contractile-Associated Proteins Involved in Pregnancy-Related Hormone Signaling , 2003, The Journal of the Society for Gynecologic Investigation: JSGI.

[34]  S. Bulun,et al.  Uterine fibroids , 2001, The Lancet.

[35]  W. Catherino,et al.  Uterine fibroids , 2016, Nature Reviews Disease Primers.

[36]  J. Coon,et al.  Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. , 2015, Human reproduction update.

[37]  J. Dungan.  Growth of uterine leiomyomata among premenopausal black and white women , 2009 .